Family Office Of America (FOFA) Cash & Equivalents (2021 - 2026)
Family Office Of America recorded quarterly Cash & Equivalents of $343220.0 in Q1 2026, up 120.3% quarter-over-quarter from $155798.0 in Q4 2025, and down 39.28% year-over-year from $565222.0 in Q1 2025.
Family Office Of America's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $343220.0 for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 39.28% year-over-year to $343220.0; the TTM figure through Mar 2026 stood at $343220.0 (down 39.28% YoY), while the FY2025 annual figure was $155798.0, up 1046.75% from the prior year.
- Cash & Equivalents came in at $343220.0 for Q1 2026 at Family Office Of America, up from $155798.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $827598.0 in Q3 2025 to a low of $1331.0 in Q3 2023.
- A 5-year average of $211882.6 and a median of $90571.0 in 2024 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents slumped 99.23% in 2023 and surged 3408.94% in 2024, its largest moves.
- Family Office Of America's Cash & Equivalents stood at $69858.0 in 2022, then plunged by 96.52% to $2431.0 in 2023, then soared by 458.86% to $13586.0 in 2024, then soared by 1046.75% to $155798.0 in 2025, then jumped by 120.3% to $343220.0 in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $343220.0, $155798.0, and $827598.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Family Office Of America | - | - | 783,126.00 | 343,220.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 343,220.00 |
| Dec 31, 2025 | 155,798.00 |
| Sep 30, 2025 | 827,598.00 |
| Jun 30, 2025 | 585,273.00 |
| Mar 31, 2025 | 565,222.00 |
| Dec 31, 2024 | 13,586.00 |
| Sep 30, 2024 | 46,704.00 |
| Jun 30, 2024 | 62,956.00 |
| Mar 31, 2024 | 90,571.00 |
| Dec 31, 2023 | 2,431.00 |
| Sep 30, 2023 | 1,331.00 |
| Jun 30, 2023 | 24,627.00 |
| Mar 31, 2023 | 16,105.00 |
| Dec 31, 2022 | 69,858.00 |
| Sep 30, 2022 | 171,952.00 |
| Jun 30, 2022 | 226,287.00 |
| Mar 31, 2022 | 398,485.00 |
| Dec 31, 2021 | 528,284.00 |
| Sep 30, 2021 | 703,921.00 |
| Jun 30, 2021 | 1.06 Mn |